$8.10
0.000.00%
Pre-Market: 4:55 PM EDT
Adaptive Biotechnologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Adaptive Biotechnologies using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $-0.23 | $-0.24 | 4.17 % |
Q3 | 2024-11-07 | $-0.22 | $-0.29 | 24.1 % |
Q2 | 2024-08-01 | $-0.31 | $-0.33 | 6.06 % |
Q1 | 2024-05-07 | $-0.33 | $-0.34 | 2.94 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-11 | $47.46M | $46.05M | 3.06 % |
Q3 | 2024-11-07 | $46.44M | $40.21M | 15.5 % |
Q2 | 2024-08-01 | $43.19M | $38.66M | 11.7 % |
Q1 | 2024-05-07 | $41.87M | $38.78M | 7.98 % |
Adaptive Biotechnologies (ADPT) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 11, 2025 for Q4.
The Actual EPS was $-0.23, which beat the estimate of $-0.24.
The Actual Revenue was $47.5M, which beat the estimate of $46M.
Browse earnings estimates, EPS, and revenue on all stocks.